The binding of transcriptional repressors at the NME1 promoter, such as the thyroid hormone receptor in hepatoma cell lines45, is unlikely responsible for the low expression of Nm23-H1 in MDA-MB-231 cells, which were incapable of showing enhanced promoter activity when transcription factor binding sites were disrupted. This evidence concerns the gene NME1 and hepatocellular carcinoma.